Interesting article from Seeking Alpha yesterday regarding revenue IF approval goes through. They estimate 200 million/year. With 100.81 million shares outstanding and a modest P/E of 10 for the industry, that would put the share price around $19-$20....IF approved. Damn.
About me, as of today (payday), I'm on the sidelines with $111,550 in my etrade account. I've missed the major move the market has had YTD. Call me old school but the fundamentals don't stand up and I don't trust it. However, as we all know, there are pockets of the market that have nothing to do with the overall economy/market/politics/etc. ZGNX is in one of them. Currently monitoring three sites for the quickest access to the decision once it is made. If approved, I'm all in. Massive market for this drug and Purdue will be late to the game.
Open to any suggestions on where to find the latest and quickest access to "the decision" when it hits. Thanks.